更新的国际共识诊断标准:AGREE会议纪要
该共识会议基于AGREE II标准,汇集14个国家消化、过敏和病理专家,更新了嗜酸性粒细胞性食管炎(EoE)诊断标准。共识认为PPI试验不再作为诊断必需,EoE诊断需有食管功能障碍症状、活检至少15个嗜酸性粒细胞/高倍视野(或约60个/mm²)并排除其他原因。
要点
- EoE诊断需食管功能障碍症状、活检≥15个嗜酸性粒细胞/高倍视野(或约60个/mm²)并排除其他非EoE病因。
- PPI试验不再作为EoE诊断标准,PPI应视为可能由EoE所致食管嗜酸性粒细胞增多的治疗。
- 共识基于AGREE II标准,由14个国家多学科专家参与制定。
核心结论
- EoE诊断应基于食管功能障碍症状、食管活检至少15个嗜酸性粒细胞/高倍视野(或约60个/mm²)并全面评估排除其他非EoE病因。
- PPI试验不再作为EoE诊断标准,PPI应归类为可能由EoE所致食管嗜酸性粒细胞增多的治疗而非诊断标准。
研究设计与样本
- 采用与AGREE II标准一致的过程召开共识会议,来自14个国家的儿科和成人胃肠病学、过敏和病理学专家参与,通过在线交流、电话会议和面对面会议回顾文献和临床经验。
主要发现
- 大量证据表明PPIs可减少儿童、青少年和成人食管嗜酸性粒细胞增多,多种机制可能解释该治疗效果。
- 基于上述发现,更新了EoE诊断算法,取消了PPI试验要求。
关键数值与推荐
- EoE诊断标准:食管功能障碍症状、食管活检至少15个嗜酸性粒细胞/高倍视野(或约60个嗜酸性粒细胞/mm²)并排除其他非EoE病因。
- PPI试验不再作为EoE诊断标准。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Over the last decade, clinical experiences and research studies raised concerns regarding use of proton pump inhibitors (PPIs) as part of the diagnostic strategy for eosinophilic esophagitis (EoE). We aimed to clarify the use of PPIs in the evaluation and treatment of children and adults with suspected EoE to develop updated international consensus criteria for EoE diagnosis. METHODS: A consensus conference was convened to address the issue of PPI use for esophageal eosinophilia using a process consistent with standards described in the Appraisal of Guidelines for Research and Evaluation II. Pediatric and adult physicians and researchers from gastroenterology, allergy, and pathology subspecialties representing 14 countries used online communications, teleconferences, and a face-to-face meeting to review the literature and clinical experiences. RESULTS: Substantial evidence documented that PPIs reduce esophageal eosinophilia in children, adolescents, and adults, with several mechanisms potentially explaining the treatment effect. Based on these findings, an updated diagnostic algorithm for EoE was developed, with removal of the PPI trial requirement. CONCLUSIONS: EoE should be diagnosed when there are symptoms of esophageal dysfunction and at least 15 eosinophils per high-power field (or approximately 60 eosinophils per mm2) on esophageal biopsy and after a comprehensive assessment of non-EoE disorders that could cause or potentially contribute to esophageal eosinophilia. The evidence suggests that PPIs are better classified as a treatment for esophageal eosinophilia that may be due to EoE than as a diagnostic criterion, and we have developed updated consensus criteria for EoE that reflect this change.
引用
- Dellon ES, Liacouras CA, Molina-Infante J, et al. Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference. Gastroenterology. 2018. PMID: 30009819. doi:10.1053/j.gastro.2018.07.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。